NL7802848A - Werkwijze voor de bereiding en toepassing van gesubstitueerde bisbenzimidazolylverbindingen. - Google Patents

Werkwijze voor de bereiding en toepassing van gesubstitueerde bisbenzimidazolylverbindingen.

Info

Publication number
NL7802848A
NL7802848A NL7802848A NL7802848A NL7802848A NL 7802848 A NL7802848 A NL 7802848A NL 7802848 A NL7802848 A NL 7802848A NL 7802848 A NL7802848 A NL 7802848A NL 7802848 A NL7802848 A NL 7802848A
Authority
NL
Netherlands
Prior art keywords
bisbenzimidazolyl
substituted
compounds
preparation
substituted bisbenzimidazolyl
Prior art date
Application number
NL7802848A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772711362 external-priority patent/DE2711362A1/de
Priority claimed from DE19782804835 external-priority patent/DE2804835A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NL7802848A publication Critical patent/NL7802848A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
NL7802848A 1977-03-16 1978-03-15 Werkwijze voor de bereiding en toepassing van gesubstitueerde bisbenzimidazolylverbindingen. NL7802848A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772711362 DE2711362A1 (de) 1977-03-16 1977-03-16 Substituierte bisbenzimidazolylthiophenverbindungen, ihre herstellung und verwendung
DE19782804835 DE2804835A1 (de) 1978-02-04 1978-02-04 Substituierte bisbenzimidazolylverbindungen, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
NL7802848A true NL7802848A (nl) 1978-09-19

Family

ID=25771734

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7802848A NL7802848A (nl) 1977-03-16 1978-03-15 Werkwijze voor de bereiding en toepassing van gesubstitueerde bisbenzimidazolylverbindingen.

Country Status (11)

Country Link
US (1) US4156778A (es)
JP (1) JPS53135978A (es)
AU (1) AU3415578A (es)
CA (1) CA1095038A (es)
ES (2) ES467739A1 (es)
FR (1) FR2383944A1 (es)
GB (1) GB1599102A (es)
IL (1) IL54275A0 (es)
IT (1) IT1094902B (es)
NL (1) NL7802848A (es)
NZ (1) NZ186689A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645874A (en) * 1982-07-16 1987-02-24 At&T Bell Laboratories Message routing through data communication networks
DE3305578A1 (de) * 1983-02-18 1984-08-23 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von 4,4'-bis-benz-ox(-thi,-imid) -azol-2-yl-stilbenen
US5643935A (en) * 1995-06-07 1997-07-01 The University Of North Carolina At Chapel Hill Method of combatting infectious diseases using dicationic bis-benzimidazoles
JP2001302643A (ja) * 2000-04-21 2001-10-31 Suntory Ltd 環状アミジン化合物
CA2430951A1 (en) * 2000-12-07 2002-06-13 Cv Therapeutics, Inc. Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
CN101143854B (zh) * 2006-09-15 2011-01-05 沈阳化工研究院 一种双苯并噁唑类化合物的合成方法
ATE534389T1 (de) * 2007-10-05 2011-12-15 Univ Mons Hainaut Bisbenzimidazole und mittel gegen malaria
CN102070551B (zh) * 2010-12-29 2012-06-20 河北星宇化工有限公司 2,2’-(4,4’-二苯乙烯基)双苯并噁唑的制备方法
CN109651370A (zh) * 2018-12-17 2019-04-19 桂林理工大学 一种嘌呤类衍生物自由基前体分子及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2733244A (en) * 1956-01-31 G-tetrahydropyrimidine and imidaz-
US3103518A (en) * 1958-01-14 1963-09-10 G -methoxybenzimidazole-
DE1166197B (de) * 1958-09-02 1964-03-26 Ciba Geigy Verfahren zur Herstellung von 2, 5-Di[benzoxazolyl-(2)]-thiophenderivaten
US3337578A (en) * 1961-09-15 1967-08-22 Heidenheimer Chemisches Lab 2, 2'-alkylenebisbenzimidazoles
US3287469A (en) * 1963-09-27 1966-11-22 Du Pont Naphthyl-and indanylimidazolines
FR1451220A (fr) * 1963-10-11 1966-01-07 Merck & Co Inc Procédé de fabrication de benzimidazoles
FR1451219A (fr) * 1963-11-15 1966-01-07 Merck & Co Inc Procédé de fabrication de benzimidazoles 2-substitués
US3179669A (en) * 1964-06-15 1965-04-20 Upjohn Co Monohydroxy substituted 2, 2'-alkyli-denebisbenzimidazoles
JPS5024314B2 (es) * 1972-12-29 1975-08-14
GB1476464A (en) * 1974-11-20 1977-06-16 Wyeth John & Brother Ltd 9-tetrahydropyrimidinyl-and 9-imidazolinyl-fluorenols their preparation and their pharmaceutical compositions
US3992403A (en) * 1975-05-30 1976-11-16 Schering Corporation 2-Imidazolines and their use as hypoglycemic agents

Also Published As

Publication number Publication date
ES467739A1 (es) 1979-07-01
IL54275A0 (en) 1978-06-15
NZ186689A (en) 1979-10-25
IT1094902B (it) 1985-08-10
CA1095038A (en) 1981-02-03
JPS53135978A (en) 1978-11-28
IT7821181A0 (it) 1978-03-13
ES475989A1 (es) 1979-05-16
AU3415578A (en) 1979-09-20
GB1599102A (en) 1981-09-30
FR2383944A1 (fr) 1978-10-13
US4156778A (en) 1979-05-29

Similar Documents

Publication Publication Date Title
NL175991C (nl) Werkwijze voor de bereiding van tetrafluorethaan.
NL189085C (nl) Werkwijze voor de bereiding van octafluorpropaan.
NL7809014A (nl) Werkwijze voor de bereiding van polyesters.
NL7713122A (nl) Werkwijze voor de bereiding van koolwaterstoffen.
NL188407C (nl) Werkwijze voor de bereiding van d(-)-alfa-fenylglycine.
NL7800165A (nl) Werkwijze voor de bereiding van polyamines.
NL7807243A (nl) Werkwijze voor de reductie van fosfienoxiden.
NL7704656A (nl) Werkwijze voor de bereiding van koolwaterstoffen.
NL181923B (nl) Werkwijze voor de bereiding van beta-aminopropionamide.
NL7811106A (nl) Werkwijze voor de bereiding van moranoline en n-methylmoranoline.
NL7803325A (nl) Werkwijze voor de bereiding van 1-azolyl-3.3- -dimethyl-1-fenoxybutan-2-on-verbindingen.
NL7802848A (nl) Werkwijze voor de bereiding en toepassing van gesubstitueerde bisbenzimidazolylverbindingen.
NL7812394A (nl) Werkwijze voor de o-hydroxymethylering van aporfines.
NL183898C (nl) Werkwijze voor de bereiding van cefamycine c.
NL7711719A (nl) Werkwijze voor de bereiding van koolwater- stoffen.
NL7806482A (nl) Werkwijze voor de bereiding van bindmiddelen.
NL7704658A (nl) Werkwijze voor de bereiding van koolwaterstoffen.
NL7705457A (nl) Werkwijze voor de bereiding van 2.3-dimethylpen- tanal.
NL187065C (nl) Werkwijze voor de bereiding van styryldifenylamine.
NL7704179A (nl) Werkwijze voor de bereiding van n-gesubstitu- eerde 2-pyrrolidonen.
NL7800026A (nl) Werkwijze voor de bereiding van gesubstitueerde amino-benzenen.
NL7710612A (nl) Werkwijze voor de bereiding van aldehyden.
NL7803629A (nl) Werkwijze voor de bereiding van gefosforileerde amidi- nen.
NL7812393A (nl) Werkwijze voor de bereiding van 1-hydroxyaporfine-deri- vaten.
NL7802881A (nl) Werkwijze voor de bereiding van triterpeenver- bindingen.